Delineate
ActiveAI-nativeAgents for Accelerated Clinical Trial Design
What it does
Delineate is building AI agents to design better clinical trials faster. This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential. We process existing clinical trial research into specialized datasets saving scientists months of effort. Delineate is working with two of the largest pharmaceutical companies. With one of our customers, we are helping them get to the next phase of trials faster by creating the largest dataset on a drug class ever constructed.
Its site says now · captured 2026-08-23
Delineate — Quantitative evidence for consequential decisions
Delineate creates models from the totality of available evidence — in any therapeutic area — so development, regulatory, and commercial teams act on quantitative evidence in a fraction of the time.
Next to it in Vertical AI agents · AI agents for clinical trial design
- Cosign AIAlchemist Accelerator Alchemist Class 39
Never miss clinical trial candidates & save months recruiting
- AdamY Combinator W25
AI Powered CAD
- DelfaEntrepreneur First EF London 2025
AI agents for clinical trial management.
- MooresLabAIPlug and Play PnP 2025
Agentic AI for Silicon Engineering
- PhasesY Combinator S25
AI for the physical world
- OuterportY Combinator S24
Design automation for industrial electrical controls
- Kenosha AIAntler Antler US 2024
Operational AI for Clinical Trial Administration
- AstraeaY Combinator X26
AI Operating System for Clinical Development